Neelam Giri

Neelam Giri's AcademicInfluence.com Rankings

Neelam Giri

Philosophy

#11977

World Rank

#16568

Historical Rank

Logic

#8790

World Rank

#11046

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Neelam Giri Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Neelam K. Giri is an Indian pediatric hematologist/oncologist and physician-scientist who researches bone marrow failure syndromes. She is a staff clinician in the clinical genetics branch at the National Cancer Institute.

(See a Problem?)

Neelam Giri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. (2014) (553)
Cancer in dyskeratosis congenita. (2009) (422)
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. (2008) (396)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. (2000) (330)
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. (2007) (326)
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study (2010) (293)
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. (2011) (249)
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita (2013) (211)
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up (2017) (202)
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita (2012) (190)
Telomere shortening and loss of self-renewal in dyskeratosis congenita iPS cells (2011) (141)
Endocrine abnormalities in patients with Fanconi anemia. (2007) (127)
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes (2010) (123)
A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, RTEL1, Underlies Severe Immunodeficiency and Features of Hoyeraal Hreidarsson Syndrome (2013) (117)
Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1 (2014) (112)
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. (2013) (106)
Genotype-phenotype associations in Fanconi anemia: A literature review. (2019) (99)
Response to androgen therapy in patients with dyskeratosis congenita (2014) (85)
Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. (2014) (79)
Invasive aspergillosis in human immunodeficiency virus-infected children. (1997) (79)
Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. (2010) (72)
Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. (2015) (71)
Novel and known ribosomal causes of Diamond-Blackfan anaemia identified through comprehensive genomic characterisation (2017) (69)
Oral and dental phenotype of dyskeratosis congenita. (2008) (68)
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus (2013) (66)
Erythrocyte adenosine deaminase: diagnostic value for Diamond‐Blackfan anaemia (2013) (63)
Telomere length in inherited bone marrow failure syndromes (2014) (62)
Dyskeratosis congenita: The first NIH clinical research workshop (2009) (61)
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review (2011) (57)
Bone Marrow Transplantation for Infantile Malignant Osteopetrosis (1995) (44)
Factors affecting hair regrowth after bone marrow transplantation. (1993) (44)
Comparison of Chromosome Breakage in Non-Mosaic and Mosaic Patients with Fanconi Anemia, Relatives, and Patients with Other Inherited Bone Marrow Failure Syndromes (2014) (41)
Thinking of VACTERL‐H? Rule out Fanconi Anemia according to PHENOS (2016) (39)
In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting. (2001) (38)
HEMATOPOIESIS AND STEM CELLS GATA 2 de fi ciency : a protean disorder of hematopoiesis , lymphatics , and immunity (2014) (37)
Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. (2015) (36)
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics. (1999) (33)
Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders (2017) (33)
Pradimicins: A novel class of broad-spectrum antifungal compounds (2005) (33)
Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony‐stimulating factor (2007) (33)
Understanding the evolving phenotype of vascular complications in telomere biology disorders (2018) (32)
Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives (2017) (32)
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. (2012) (31)
Anti-Müllerian hormone deficiency in females with Fanconi anemia. (2014) (31)
Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. (1996) (30)
Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita (2006) (30)
Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up. (2016) (27)
The relationship between DNA methylation and telomere length in dyskeratosis congenita (2012) (26)
Immune status of patients with inherited bone marrow failure syndromes (2015) (26)
Failure of allogeneic bone marrow transplantation to benefit HIV infection (1992) (26)
Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? (2012) (25)
Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita. (2018) (25)
Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations (2016) (25)
Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukaemia. (1992) (24)
Novel FANCI mutations in Fanconi anemia with VACTERL association (2015) (24)
Research participant interest in primary, secondary and incidental genomic findings (2016) (23)
Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes (2013) (22)
Re‐equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction (2020) (22)
Genetic analysis and clinical picture of severe congenital neutropenia in Israel (2015) (21)
The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita (2016) (20)
Long‐term complications following bone marrow transplantation in children (1993) (18)
Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes (2013) (17)
Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance (2020) (17)
Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes. (2015) (17)
Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort. (2017) (16)
Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita (2017) (16)
Disease Progression and Clinical Outcomes in Telomere Biology Disorders. (2021) (15)
Antifungal Activity of the Pradimicin Derivative BMS 181184 in the Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits (1998) (14)
Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes. (2014) (14)
Proliferative retinopathy as a complication of dyskeratosis congenita. (2009) (13)
Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita (2011) (13)
CNS manifestations in patients with telomere biology disorders (2019) (12)
HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases. (1994) (12)
The effects of SCF/G-CSF prestimulation on radiation sensitivity and engraftment in nonmyeloablated murine hosts. (2001) (11)
Genotype-phenotype association and variant characterization in Diamond Blackfan anemia caused by pathogenic variants in RPL35A (2020) (11)
Compartmental Pharmacokinetics and Tissue Drug Distribution of the Pradimicin Derivative BMS 181184 in Rabbits (1998) (11)
All in the family: Disclosure of “unwanted” information to an adolescent to benefit a relative (2008) (10)
Bone Mineral Density in Patients with Inherited Bone Marrow Failure Syndromes (2017) (9)
Cancer in the National Cancer Institute Inherited Bone Marrow Failure Syndrome Cohort after 15 Years of Follow-up (2016) (9)
Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes (2016) (9)
Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder (2019) (8)
Expansion of germline RPS20 mutation phenotype to include Diamond–Blackfan anemia (2020) (8)
Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders. (2020) (8)
Complex phenotype of dyskeratosis congenita and mood dysregulation with novel homozygous RTEL1 and TPH1 variants (2018) (8)
Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure. (2017) (7)
Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2). (2021) (6)
RPS29 is Mutated in a Multi-Case Diamond Blackfan Anemia Family (2012) (6)
Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes (2018) (6)
Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort (2022) (5)
Engraftment failure following bone marrow transplantation in children with thalassemia major using busulfan and cyclophosphamide conditioning. (1997) (5)
Response to Androgen Therapy and Side Effects in Patients with Dyskeratosis Congenita. (2012) (4)
Cancer Epidemiology in the National Cancer Institute Inherited Bone Marrow Failure Syndromes Cohort: First Report (2008) (4)
Shwachman Diamond syndrome: narrow genotypic spectrum and variable clinical features (2022) (3)
1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius–like phenotypes (2019) (3)
Correlation of Telomere Length in Blood, Buccal Cells, and Fibroblasts From Patients with Inherited Bone Marrow Failure Syndromes. (2009) (3)
Differential diagnosis of bone marrow failure syndromes guided by machine learning. (2022) (3)
The inherited bone marrow failure syndromes (2004) (3)
Risk of cancer in heterozygous relatives of patients with Fanconi anemia. (2021) (3)
Phenotypes of Diamond Blackfan Anemia Patients with RPL35A Haploinsufficiency Due to 3q29 Deletion Compared with RPL35A Single Nucleotide Variants or Small Insertion/Deletions (2018) (3)
The incidence and spectrum of congenital hand differences in patients with Fanconi anaemia: analysis of 48 patients (2022) (2)
Genotype-Phenotype Associations in Patients with Fanconi Anemia: National Cancer Institute Cohort (2020) (2)
Head and neck cancer in Fanconi anemia and dyskeratosis congenita. (2012) (2)
Gynaecological and reproductive health of women with telomere biology disorders (2021) (2)
Cancer in Heterozygote Carriers of Fanconi Anemia Genes (2018) (2)
TINF2 , a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita. (2007) (1)
Novel and Known Ribosomal Causes of Diamond-Blackfan Anemia Identified through Comprehensive Genomic Characterization (2016) (1)
Comparative Efﬁcacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System (1)
Fertility and Pregnancy Outcomes in Females with Dyskeratosis Congenita (2014) (1)
Corrigendum: 1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius–like phenotypes (2019) (1)
Very Short Telomeres Are Characteristic of Dyskeratosis Congenita and Not Other Inherited Bone Marrow Failure Syndromes (2008) (1)
Bone marrow skeletal stem / progenitor cell defects in patients with dyskeratosis congenita and telomere biology disorders (2014) (1)
Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita (2021) (1)
Large Genomic Deletions in Shwachman-Diamond Syndrome (2018) (1)
Pituitary abnormalities in patients with Fanconi anaemia (2016) (1)
identifies patients with dyskeratosis congenita Very short telomere length by flow fluorescence in situ hybridization (2011) (1)
Clinically Silent Carriers in Families with Myelodysplastic Syndrome Due to GATA2 Mutations (2012) (1)
Prognostic Significance of Pulmonary Function Test Abnormalities in Patients with Dyskeratosis Congenita (2016) (1)
Genomic-Based Machine Learning Towards Prediction of the Etiology of Bone Marrow Failure Syndromes (2021) (1)
De Novo RPS20 Mutations in Diamond Blackfan Anemia (2014) (1)
Evaluating The Utility Of Telomere Length Measurement By Qpcr As a Diagnostic Test For Dyskeratosis Congenita (2013) (1)
The HPV Status of Patients with Fanconi Anemia. (2012) (0)
Higher Than Expected Carrier Frequency Of The Dyskeratosis Congenita RTEL1 p.Arg1264His recessive Founder In Individuals Of Ashkenazi Jewish Ancestry (2013) (0)
Central Nervous System Abnormalities in Dyskeratosis Congenita and Fanconi Anemia: Correlation with Clinical Phenotype and Aplastic Anemia. (2007) (0)
Bone Marrow Cellular Composition and Inflammatory Cytokine Expression in Patients with Inherited Bone Marrow Failure Syndromes (2012) (0)
Prospective Phase I/II Study of Eltrombopag for the Treatment of Bone Marrow Failure in Fanconi Anemia (2021) (0)
Studies of Immune Function In the Inherited Bone Marrow Failure Syndromes. (2010) (0)
Bone Marrow Fibrosis in Patients with Inherited Bone Marrow Failure Syndromes. (2009) (0)
Functional Consequences Of RPS29 Germline Mutations In Diamond-Blackfan Anemia (2013) (0)
Faculty Opinions recommendation of Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium. (2010) (0)
Mutations In TCAB1 Cause Dyskeratosis Congenita (2010) (0)
Understanding the evolving phenotype of vascular complications in telomere biology disorders (2018) (0)
Phase II Study of Eltrombopag in Subjects with Fanconi Anemia (2019) (0)
Immunoglobulin and Lymphocyte Subset Abnormalities in Patients with Fanconi Anemia and Dyskeratosis Congenita. (2006) (0)
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita (2013) (0)
202 TINF2 mutations are associated with severe mucocutaneous disease in dyskeratosis congenita (2017) (0)
Ophthalmic Manifestations of the Inherited Bone Marrow Failure Syndromes (2009) (0)
Disease Progression and Outcomes in Patients with Telomere Biology Disorders (2020) (0)
Faculty Opinions recommendation of Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. (2012) (0)
Variable Clinical Features in a Large Family With Diamond Blackfan Anemia Caused by a Pathogenic Missense Mutation in RPS19 (2022) (0)
Significance of Bone Marrow Karyotype and Morphology in Patients with Inherited Bone Marrow Failure Syndromes (2011) (0)
Stress Erythropoiesis and Genetic Regulation of Fetal Hemoglobin in Inherited Bone Marrow Failure Syndromes (2011) (0)
Diagnosis of Fanconi Anemia in An Asymptomatic Adult with Mosaicism and a Molecular Explanation. (2009) (0)
Serum alpha fetoprotein levels in Fanconi anaemia (2018) (0)
Pathogenic germline IKZF1 variant alters hematopoietic gene expression profiles (2021) (0)
The First Single Center Phenotypic Comparison of Fanconi Anemia, Dyskeratosis Congenita, Diamond-Blackfan Anemia, and Shwachman- Diamond Syndrome: The NCI IBMFS Cohort. (2008) (0)
Fanconi anaemia: A syndrome with distinct subgroups (2022) (0)
FANCA Variants in Exons 27-30 Are Associated with Solid Tumors in Fanconi Anemia (2021) (0)
Cover Image, Volume 176A, Number 6, June 2018 (2018) (0)
Avascular Necrosis and Minimal Trauma Bone Fractures in Patients with Dyskeratosis Congenita (2022) (0)
Thrombocytopenia, multiple mucosal squamous cell carcinomas, and dyspigmentation. (2006) (0)
Germline Mutations in RTEL1 cause Dyskeratosis Congenita (2012) (0)
Persistent Questions about the Treatment of Severe Aplastic Anemia in Children as Illustrated by Five Cases (2003) (0)
Longitudinal Changes In Telomere Length In Patients with Dyskeratosis Congenita (2010) (0)
EP1236: UNDERSTANDING LIVER DISEASE AND IT'S PROGRESSION IN DYSKERATOSIS CONGENITA AND RELATED TELOMERE BIOLOGY DISORDERS (2022) (0)
OI0422 Oral leukoplakia in dyskeratosis congenita: associations between genotype and phenotype (2014) (0)
NCI Fanconi’s Anemia Cohort: Hematology and Beyond. (2005) (0)

This paper list is powered by the following services:

Other Resources About Neelam Giri

en.wikipedia.org

What Schools Are Affiliated With Neelam Giri?

Neelam Giri is affiliated with the following schools:

Thomas Jefferson University